cerebral venouse sinus thrombosis. Other vascular syndromes of brain in cerebrovascular diseases
Conditions
Interventions
Intervention 1: low molecular weight heparin 1mg/kg S/C twice a day for 7days. Intervention 2: unfractionated heparin 25000-65000 u IV daily for 7days.
Treatment - Drugs
low molecular weight heparin 1mg/kg S/C twice a day for 7days.
unfractionated heparin 25000-65000 u IV daily for 7days.
Sponsors
Vice-chancellor for research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criterion: the patients with cerebral venouse thrombosis diagnosed on the basis of MR venography. Exclusion criteria: age of <18 years old; contraindications for anticoagulant; bleeding disorder; hepatic or renal dysfunction; uncontrolled hypertension; thrombocytopenia; gastrointestinal hemorrhage; papilledema with impaired vision that required lumbar punctures.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measure of global disability. Timepoint: before of the trearment,discharge time,one month after discharge. Method of measurement: according to modified Rankin scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Focal neurologic deficit. Timepoint: before of treatment,discharge time,one month after discharge. Method of measurement: NIH Stroke scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Dariush Afshari
Kermanshah University of Medical Sciences
Outcome results
None listed